CORRECTION article

Front. Cardiovasc. Med., 06 November 2025

Sec. Cardiovascular Epidemiology and Prevention

Volume 12 - 2025 | https://doi.org/10.3389/fcvm.2025.1696969

Correction: The Gulliver syndrome: a conceptual framework to address therapeutic inertia in patients with borderline cardiovascular risk profiles

  • 1. School of Medicine, Universidad Espíritu Santo, Samborondón, Ecuador

  • 2. Vicerrectoría de Investigación y Postgrado, Universidad de Los Lagos, Osorno, Chile

  • 3. Servicio de Cardiología, Hospital General Universitario Santa Lucía, Cartagena, Spain

  • 4. Sociedad Murciana de Hipertensión Arterial y Riesgo Cardiovascular, Cátedra de Riesgo Cardiovascular, Universidad Católica de Murcia, Murcia, Spain

Article metrics

View details

701

Views

55

Downloads

Reference 10 for McEvoy et al. was erroneously written as “McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. (2024) 45(38):3912–4018. doi: 10.1093/eurheartj/ehae178It”.

This reference should be:

“Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, Abdalla M, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. (2025) 152(11). doi: 10.1161/CIR.0000000000001356”.

There were errors in the Description and Mandatory criteria sections of Figure 1.

The text previously read:

Description

  • “…analogous to the cumulative effect of the Lilliputians’ rapes.”

Major cardiovascular risk factors

  • WC: 90–102♂ cm/80–88♀ cm.

  • SBP: 120–139 mm Hg; DBP: 80–89 mm Hg.

  • FBG: 100–125 mg/dL.

The corrected text is below:

Description

  • “…analogous to the cumulative effect of the Lilliputians’ ropes.”

Mandatory criteria

All 4 must be present:

  • WC: 90–101 cm (men)/80–87 cm (women).

  • SBP: 120–139 mm Hg and/or DBP: 80–89 mm Hg.

  • FPG: 100–125 mg/dL.

There was a mistake in the caption of Figure 1 as published: “FBG, Fasting blood glucose” should be “FPG, Fasting plasma glucose.”

The updated Figure 1 and its caption appear below.

Figure 1

Illustration titled \“Gulliver Syndrome\” showing a man tied down by ropes held by small figures, symbolizing slightly elevated cardiovascular risk factors. Description highlights cumulative risk akin to Lilliputians' ropes. Mandatory criteria include waist circumference, blood pressure, fasting plasma glucose, and non-HDL cholesterol levels. Clinical implications emphasize early intervention for mildly abnormal findings to reduce risk.

Graphical representation of the Gulliver syndrome. A patient's overall cardiovascular risk increases when multiple mildly elevated risk factors coexist. Each rope represents a single, subclinical abnormality (waist circumference, blood pressure, glucose, or non-high-density lipoprotein colesterol) that collectively restrain health, analogous to the ropes of the Lilliputians. DBP, diastolic blood pressure; FPG, Fasting plasma glucose; HDL, high-density lipoprotein; SBP, systolic blood pressure; WC, waist circumference.

A correction has been made to the values and terms in the sections “Proposed definition and diagnostic criteria” and “Case illustration”.

The text previously read:

Proposed definition and diagnostic criteria

  • -

    Systolic blood pressure (SBP): 121–139 mmHg and/or diastolic blood pressure (DBP): 81–89 mmHg.

  • -

    Fasting plasma glucose (FPG): 101–125 mg/dL.

Case illustration

HDL-C.

The corrected text is below:

Proposed definition and diagnostic criteria

  • -

    Systolic blood pressure (SBP): 120–139 mmHg and/or diastolic blood pressure (DBP): 80–89 mmHg.

  • -

    Fasting plasma glucose (FPG): 100–125 mg/dL.

Case illustration

  • -

    HDL cholesterol.

The original version of this article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

obesity, hypertension, diabetes mellitus, cholesterol, biomarkers

Citation

López-Gil JF, Abellán-Huerta J and Abellán-Alemán J (2025) Correction: The Gulliver syndrome: a conceptual framework to address therapeutic inertia in patients with borderline cardiovascular risk profiles. Front. Cardiovasc. Med. 12:1696969. doi: 10.3389/fcvm.2025.1696969

Received

29 September 2025

Accepted

17 October 2025

Published

06 November 2025

Volume

12 - 2025

Edited and reviewed by

Dexter Canoy, Newcastle University, United Kingdom

Updates

Copyright

* Correspondence: José Francisco López-Gil

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics